相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study
Andrea Giacomelli et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Genomic evidence for reinfection with SARS-CoV-2: a case study
Richard L. Tillett et al.
LANCET INFECTIOUS DISEASES (2021)
Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm
Alice S. Chau et al.
ARTHRITIS & RHEUMATOLOGY (2021)
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)
Chaolin Huang et al.
LANCET (2021)
Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19
Peter A. Szabo et al.
IMMUNITY (2021)
Sixty-Day Outcomes Among Patients Hospitalized With COVID-19
Vineet Chopra et al.
ANNALS OF INTERNAL MEDICINE (2021)
Post-acute COVID-19 syndrome
Ani Nalbandian et al.
NATURE MEDICINE (2021)
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Laura Montefusco et al.
NATURE METABOLISM (2021)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
Hong-Yi Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Luciano Gattinoni et al.
INTENSIVE CARE MEDICINE (2020)
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Waleed Alhazzani et al.
INTENSIVE CARE MEDICINE (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
The versatile heparin in COVID-19
Jecko Thachil
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Prevalence and impact of diabetes among people infected with SARS-CoV-2
G. P. Fadini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Covid-19-The Search for Effective Therapy
Lindsey R. Baden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Sebastiano Bruno Solerte et al.
ACTA DIABETOLOGICA (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Persistent Symptoms in Patients After Acute COVID-19
Angelo Carfi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019
Chengshui Chen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project)
Sophie Juul et al.
SYSTEMATIC REVIEWS (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Single-cell landscape of immunological responses in patients with COVID-19
Ji-Yuan Zhang et al.
NATURE IMMUNOLOGY (2020)
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A. Juno et al.
NATURE MEDICINE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Sebastiano Bruno Solerte et al.
DIABETES CARE (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
Sara De Biasi et al.
NATURE COMMUNICATIONS (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Prostaglandin E2 Stimulates the Expansion of Regulatory hematopoietic Stem and Progenitor Cells in Type 1 Diabetes
Moufida Ben Nasr et al.
FRONTIERS IN IMMUNOLOGY (2018)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes
Moufida Ben Nasr et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
IL-21 Is an Antitolerogenic Cytokiine of the Late-Phase Alloimmune Response
Alessandra Petrelli et al.
DIABETES (2011)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
Mechanisms of PDL-1 mediated regulation of autoimmune diabetes
Indira Guleria et al.
CLINICAL IMMUNOLOGY (2007)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)